TerrAscend Q3 Financial Report Reveals Major Declines In Income And EBITDA

TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF), a constituent in the munKNEE American Cannabis MSO Stocks Index, reported its financial results for the third quarter ending September 30, 2022, on Monday, November 14th, as follows:

Q3 Financial Highlights

(The information below compares Q3 2022 with Q2 2022 and all figures are in U.S. dollars.)

  • Net Revenue: UP 3.4% to $67M.
  • Gross Profit: UP 4.8% to $24.4M.
    • Gross Profit Margin: UP to 36.3% from 35.5%.
  • Adjusted Gross Profit: UP 1.3% to $30.9M.
    • Adjusted Gross Profit Margin: DOWN to 46.1% from 47.1%.
  • SG&A Exp.: DOWN 9.5% to $26.7M.
  • Adjusted EBITDA: DOWN 96.6% to $11.3M.
    • Adjusted EBITDA Margin: UP to 16.9% from 8.9%.
  • Net Income (Loss): UP to $(311)M from $14.2M income.
    • A $331 non-cash impairment charge was recorded against goodwill and intangibles for the Company's Michigan business.
  • Cashflow from Operations: UP to $1.5M from $(16.1)M.
  • Cash and Cash Equivalents: $34.3M.

Management Commentary

 Jason Wild, Executive Chairman, said:

  • "We...reduced our operating expenses in the quarter while still generating record sales...driving substantial improvement in adjusted EBITDA margins quarter over quarter and positive cash flow from operations.
  • ...We have established ourselves as a leading operator in New Jersey with three of the top ten flower SKUs, including #1.
  • We plan to deploy our branded strategy in Maryland and Pennsylvania  when these states implement adult use."

Q3 Operational Highlights

  • Entered into an agreement to exclusively introduce the Cookies brand to Pennsylvania.
  • Appointed Karim Bouaziz as President of the Northeast Region.
  • Closed on the acquisition of Pinnacle in Michigan, which includes six dispenary licenses, five of which are currently operational.
  • Opened third New Jersey Apothecarium Dispensary in Lodi.
  • Opened "Cookies Corners" at all three Apothecarium locations in New Jersey.

Stock Performance

TerrAscend's stock price:

  • declined 44% during Q3 (July, August, and September),
  • advanced 20% during October,
  • remained unchanged leading up to the release of the Q3 financials after the markets closed on November 14th but
  • advanced 14% as of the close of business today but is still
  • down 72% YTD.

More By This Author:

Verano Q3 Financial Report Reveals Major Increase In Net Loss
Trulieve Cannabis Q3 Financials Were Down But Stock Price Jumps
Cresco Labs Q3 Financials Show No Improvement Over Q2 Results

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.